Assessment of cefazolin and cefuroxime tissue penetration by using a continuous intravenous infusion

J. E. Connors, J. T. DiPiro, R. G. Hayter, K. D. Hooker, J. A. Stanfield, Timothy R Young

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

A continuous intravenous infusion was used to assess the tissue penetration of cefazolin (14 subjects) and cefuroxime (15 subjects) in orthopedic surgery patients. Subjects were randomly assigned to receive a continuous intravenous infusion of cefazolin (mean, 178.6 mg/h) or cefuroxime (mean, 330.0 mg/h) at a rate estimated to achieve a target steady-state total concentration of 50 μg/ml in serum. The infusion was initiated 12 to 14 h before surgery, and blood and muscle tissue samples were collected intraoperatively at the times of incision was wound closure. Although there was a significant difference between the free concentrations of cefazolin (at incision, 9.3 μg/ml; at closure, 9.2 μg/ml) and cefuroxime in serum (at incision, 26.9 μg/ml; at closure, 31.8 μg/ml), there was no difference in the total concentrations in muscle at either surgical incision (cefazolin, 6.1 μg/g; cefuroxime, 5.6 μg/g) or wound closure (cefazolin, 7.7 μg/g; cefuroxime, 7.4 μg/g). There was a significant correlation between the pooled free serum and total muscle concentrations for cefazolin (P = 0.001); however, there was no correlation between these variables with the pooleed cefuroxime data (P = 0.403). These findings indicate that the free drug concentration in serum alone is not consistently predictive of the total concentration of cephalosporin in muscle.

Original languageEnglish (US)
Pages (from-to)1128-1131
Number of pages4
JournalAntimicrobial Agents and Chemotherapy
Volume34
Issue number6
DOIs
StatePublished - Jan 1 1990

Fingerprint

Cefazolin
Cefuroxime
Intravenous Infusions
Muscles
Serum
Wounds and Injuries
Cephalosporins
Orthopedics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Connors, J. E., DiPiro, J. T., Hayter, R. G., Hooker, K. D., Stanfield, J. A., & Young, T. R. (1990). Assessment of cefazolin and cefuroxime tissue penetration by using a continuous intravenous infusion. Antimicrobial Agents and Chemotherapy, 34(6), 1128-1131. https://doi.org/10.1128/AAC.34.6.1128

Assessment of cefazolin and cefuroxime tissue penetration by using a continuous intravenous infusion. / Connors, J. E.; DiPiro, J. T.; Hayter, R. G.; Hooker, K. D.; Stanfield, J. A.; Young, Timothy R.

In: Antimicrobial Agents and Chemotherapy, Vol. 34, No. 6, 01.01.1990, p. 1128-1131.

Research output: Contribution to journalArticle

Connors, JE, DiPiro, JT, Hayter, RG, Hooker, KD, Stanfield, JA & Young, TR 1990, 'Assessment of cefazolin and cefuroxime tissue penetration by using a continuous intravenous infusion', Antimicrobial Agents and Chemotherapy, vol. 34, no. 6, pp. 1128-1131. https://doi.org/10.1128/AAC.34.6.1128
Connors, J. E. ; DiPiro, J. T. ; Hayter, R. G. ; Hooker, K. D. ; Stanfield, J. A. ; Young, Timothy R. / Assessment of cefazolin and cefuroxime tissue penetration by using a continuous intravenous infusion. In: Antimicrobial Agents and Chemotherapy. 1990 ; Vol. 34, No. 6. pp. 1128-1131.
@article{030218c8086d47d8bb56f049ecd76a7c,
title = "Assessment of cefazolin and cefuroxime tissue penetration by using a continuous intravenous infusion",
abstract = "A continuous intravenous infusion was used to assess the tissue penetration of cefazolin (14 subjects) and cefuroxime (15 subjects) in orthopedic surgery patients. Subjects were randomly assigned to receive a continuous intravenous infusion of cefazolin (mean, 178.6 mg/h) or cefuroxime (mean, 330.0 mg/h) at a rate estimated to achieve a target steady-state total concentration of 50 μg/ml in serum. The infusion was initiated 12 to 14 h before surgery, and blood and muscle tissue samples were collected intraoperatively at the times of incision was wound closure. Although there was a significant difference between the free concentrations of cefazolin (at incision, 9.3 μg/ml; at closure, 9.2 μg/ml) and cefuroxime in serum (at incision, 26.9 μg/ml; at closure, 31.8 μg/ml), there was no difference in the total concentrations in muscle at either surgical incision (cefazolin, 6.1 μg/g; cefuroxime, 5.6 μg/g) or wound closure (cefazolin, 7.7 μg/g; cefuroxime, 7.4 μg/g). There was a significant correlation between the pooled free serum and total muscle concentrations for cefazolin (P = 0.001); however, there was no correlation between these variables with the pooleed cefuroxime data (P = 0.403). These findings indicate that the free drug concentration in serum alone is not consistently predictive of the total concentration of cephalosporin in muscle.",
author = "Connors, {J. E.} and DiPiro, {J. T.} and Hayter, {R. G.} and Hooker, {K. D.} and Stanfield, {J. A.} and Young, {Timothy R}",
year = "1990",
month = "1",
day = "1",
doi = "10.1128/AAC.34.6.1128",
language = "English (US)",
volume = "34",
pages = "1128--1131",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "6",

}

TY - JOUR

T1 - Assessment of cefazolin and cefuroxime tissue penetration by using a continuous intravenous infusion

AU - Connors, J. E.

AU - DiPiro, J. T.

AU - Hayter, R. G.

AU - Hooker, K. D.

AU - Stanfield, J. A.

AU - Young, Timothy R

PY - 1990/1/1

Y1 - 1990/1/1

N2 - A continuous intravenous infusion was used to assess the tissue penetration of cefazolin (14 subjects) and cefuroxime (15 subjects) in orthopedic surgery patients. Subjects were randomly assigned to receive a continuous intravenous infusion of cefazolin (mean, 178.6 mg/h) or cefuroxime (mean, 330.0 mg/h) at a rate estimated to achieve a target steady-state total concentration of 50 μg/ml in serum. The infusion was initiated 12 to 14 h before surgery, and blood and muscle tissue samples were collected intraoperatively at the times of incision was wound closure. Although there was a significant difference between the free concentrations of cefazolin (at incision, 9.3 μg/ml; at closure, 9.2 μg/ml) and cefuroxime in serum (at incision, 26.9 μg/ml; at closure, 31.8 μg/ml), there was no difference in the total concentrations in muscle at either surgical incision (cefazolin, 6.1 μg/g; cefuroxime, 5.6 μg/g) or wound closure (cefazolin, 7.7 μg/g; cefuroxime, 7.4 μg/g). There was a significant correlation between the pooled free serum and total muscle concentrations for cefazolin (P = 0.001); however, there was no correlation between these variables with the pooleed cefuroxime data (P = 0.403). These findings indicate that the free drug concentration in serum alone is not consistently predictive of the total concentration of cephalosporin in muscle.

AB - A continuous intravenous infusion was used to assess the tissue penetration of cefazolin (14 subjects) and cefuroxime (15 subjects) in orthopedic surgery patients. Subjects were randomly assigned to receive a continuous intravenous infusion of cefazolin (mean, 178.6 mg/h) or cefuroxime (mean, 330.0 mg/h) at a rate estimated to achieve a target steady-state total concentration of 50 μg/ml in serum. The infusion was initiated 12 to 14 h before surgery, and blood and muscle tissue samples were collected intraoperatively at the times of incision was wound closure. Although there was a significant difference between the free concentrations of cefazolin (at incision, 9.3 μg/ml; at closure, 9.2 μg/ml) and cefuroxime in serum (at incision, 26.9 μg/ml; at closure, 31.8 μg/ml), there was no difference in the total concentrations in muscle at either surgical incision (cefazolin, 6.1 μg/g; cefuroxime, 5.6 μg/g) or wound closure (cefazolin, 7.7 μg/g; cefuroxime, 7.4 μg/g). There was a significant correlation between the pooled free serum and total muscle concentrations for cefazolin (P = 0.001); however, there was no correlation between these variables with the pooleed cefuroxime data (P = 0.403). These findings indicate that the free drug concentration in serum alone is not consistently predictive of the total concentration of cephalosporin in muscle.

UR - http://www.scopus.com/inward/record.url?scp=0025332707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025332707&partnerID=8YFLogxK

U2 - 10.1128/AAC.34.6.1128

DO - 10.1128/AAC.34.6.1128

M3 - Article

C2 - 2393271

AN - SCOPUS:0025332707

VL - 34

SP - 1128

EP - 1131

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 6

ER -